Liver diseases, both acute and chronic, continue to pose significant clinical challenges due to high morbidity and mortality ...

In an exciting development for drug development and patient care, the FDA has officially accepted the first submission of an organ-on-a-chip technology under its Innovative Science and Technology ...

Bilirubin, the primary breakdown product of hemoproteins, particularly hemoglobin, plays a key role in the diagnosis, prognosis, and monitoring of liver diseases. In acute liver diseases, such as ...

Bilirubin, the primary breakdown product of hemoproteins, particularly hemoglobin, plays a key role in the diagnosis, prognosis, and monitoring of liver diseases. In acute liver diseases, such as ...

We also looked at safety in which we looked at hypersensitivity reactions (HSR) and drug-induced liver injury (DILI). HSR ...

RAPT Therapeutics (RAPT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...

Researchers used a scalable human liver microtissue model to accurately predict the drug-induced liver injury concern of 152 ...

Dr. Palmer trained in Hepatology at Mount Sinai School of Medicine, where she also received her M.D. degree. She also holds a B.S. from Columbia University and is a Fellow of the American Association ...

The success surrounding the medications for obesity and diabetes has sparked research into whether they could also be an ...

These symptoms vary slightly based on whether the red blood cell is broken down while in circulation (intravascular hemolysis) or outside the vascular system (predominantly liver and spleen).

Following Saturday night's game, Roberts sounded confident that Ohtani had avoided serious injury, but the Dodgers designated hitter had to go undergo further testing to confirm. On Sunday ...